Jeff A. Sloan
Jeff A. Sloan publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, on topics such as Cancer survivorship and care, Cancer Treatment and Pharmacology and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #18,553 of 7,710,434 ranked researchers
- Rank in United States
- #6,686 of 1,627,098
- Works
- 727
- Citations
- 75k
- Citations per work
- 102.8
What does Jeff A. Sloan research?
Jeff A. Sloan's work is mostly in Medicine (41%), Economics, Econometrics and Finance (6%), Health Professions (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else35348.6%
- Health Sciences33345.8%
- Medicine29740.9%
- Health Professions364.9%
- Social Sciences415.6%
- 1Oncology20% of their works
- 2Pulmonary and Respiratory Medicine9% of their works
- 3Public Health, Environmental and Occupational Health7% of their works
- 4Economics and Econometrics6% of their works
- 5Surgery5% of their works
- 6General Health Professions5% of their works
Research topics
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare professionals’ stress and burnout
- Palliative Care and End-of-Life Issues
- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Childhood Cancer Survivors' Quality of Life
Which keywords describe Jeff A. Sloan's research?
The keywords of their largest research topics: Quality of Life, Anxiety, Depression, Health-related Quality of Life, Cancer Survivorship, Patient-Reported Outcomes, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- Pediatric Quality of Life Inventory
- Targeted Therapy
- KRAS Mutations
- Palliative Care
- Work-Life Balance
- Health Utility Measures
- Taxanes
- Patient-Reported Outcomes
- Health-related Quality of Life
- Anxiety
- Quality of Life
- Depression
- Cancer Survivorship
- Chemotherapy-Induced Peripheral Neuropathy
- Cost-effectiveness Analysis
- Physician Burnout
- End-of-Life
- Cetuximab
- EGFR Mutations
- Childhood Cancer Survivor Study
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Quality of Life3123 topics
- Anxiety2142 topics
- Depression2142 topics
- Health-related Quality of Life1962 topics
- Cancer Survivorship1591 topic
- Patient-Reported Outcomes1591 topic
- Chemotherapy-Induced Peripheral Neuropathy801 topic
- Taxanes801 topic
- Cost-effectiveness Analysis731 topic
- Health Utility Measures731 topic
- Physician Burnout551 topic
- Work-Life Balance551 topic
- End-of-Life521 topic
- Palliative Care521 topic
- Cetuximab441 topic
- KRAS Mutations441 topic
- EGFR Mutations431 topic
- Targeted Therapy431 topic
- Childhood Cancer Survivor Study371 topic
- Pediatric Quality of Life Inventory371 topic
Where does Jeff A. Sloan work?
Jeff A. Sloan's main affiliation in the publication record is Mayo Clinic, United States.
How many publications and citations does Jeff A. Sloan have?
OpenAlex counts 727 works and 74,749 citations for Jeff A. Sloan, an h-index of 126, ranking #18,553 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jeff A. Sloan
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jeff A. Sloan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.